Valuation: Shivalik Rasayan Limited

Market Cap 618.28Cr 6.42Cr 5.7Cr 5.33Cr 4.86Cr 9.15Cr 9.28Cr 65Cr 25Cr 314.88Cr 24Cr 24Cr 1.01TCr P/E 2025
59.1x
P/E 2026 28.2x
Enterprise Value 706.7Cr 7.34Cr 6.52Cr 6.1Cr 5.56Cr 10Cr 11Cr 74Cr 29Cr 359.91Cr 28Cr 27Cr 1.16TCr EV / Sales 2025
3.4x
EV / Sales 2026 1.21x
Free-Float
42.93%
Yield 2025
0.08%
Yield 2026 0.23%
14/08 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
23/07 Shivalik Rasayan Limited announced that it expects to receive INR 152.25 million in funding from Bishnoi Exports Private Limited, Growel Remedies Limited, Kim Ginnerup ApS and other investors CI
27/05 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
27/05 Shivalik Rasayan Limited Announces Resignation of Sanjay Bansal as Non-Executive Director, Effective May 27, 2026 CI
27/05 Shivalik Rasayan Limited Recommends Final Dividend for the Financial Year 2025-26, Payable on or After October 15, 2026 CI
27/05 Shivalik Rasayan Ltd March-quarter consol net profit 45.3 million rupees RE
13/02 Shivalik Rasayan Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
14/11 Shivalik Rasayan Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
29/25/29 Shivalik Rasayan Limited Approves the Re-Designation of Mr. Ashwani Kumar Sharma as a Non-Executive, Non-Independent Director CI
12/25/12 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/25/30 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
30/25/30 Shivalik Rasayan Limited announces Annual dividend, payable on October 27, 2025 CI
24/25/24 Medicamen Biotech Limited announced that it has received INR 535.6816 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD and other investors CI
1 day-2.24%
1 week-4.09%
Current month-2.24%
1 month+15.52%
3 months+69.09%
6 months+70.01%
Current year+10.31%
1 week 372.15
Extreme 372.15
430.05
1 month 310
Extreme 310
437.9
Current year 206
Extreme 206
437.9
1 year 206
Extreme 206
474.2
3 years 206
Extreme 206
873.6
5 years 206
Extreme 206
1,196.8
10 years 65.14
Extreme 65.14
1,196.8
Manager TitleAgeSince
Chief Executive Officer 64 17/11/2018
Director of Finance/CFO - 01/11/2001
Compliance Officer - 01/08/2017
Director TitleAgeSince
Chairman 62 23/02/2002
Director/Board Member 67 18/07/2003
Director/Board Member - 13/11/2018
Date Insider Type Main position Quantity % Market Cap. Importance
01/07/24 Don 21,500 0.1382%
26/06/24 Sell 1,08,500 0.6973%
Change 5-day change 1-year change 3-year change Capi.($)
-2.24%-4.09%-10.16%-47.18% 6.6Cr
+7.90%-83.99%-80.20%-74.89% 5.18TCr
-0.67%-5.16%+25.74%+18.35% 3.36TCr
+1.40%+0.55%+14.29%+38.87% 1.88TCr
-0.57%-3.29%+32.52%+33.59% 1.74TCr
-0.60%-5.66%-1.93%-13.50% 1.49TCr
+0.11%-.--%-.--%-.--% 1.3TCr
+0.12%+0.12%+25.75%+193.13% 1.13TCr
-1.82%-6.52%+11.85%+2.22% 1.12TCr
-0.22%-.--%-.--%-.--% 829.58Cr
Average +0.34%-11.28%+1.79%+15.06% 1.8TCr
Weighted average by Cap. +2.08%-26.52%-11.43%+0.30%

Financials

2025 2026
Net sales 309.55Cr 3.22Cr 2.86Cr 2.67Cr 2.43Cr 4.58Cr 4.64Cr 32Cr 13Cr 157.65Cr 12Cr 12Cr 506.36Cr 361.62Cr 3.76Cr 3.34Cr 3.12Cr 2.84Cr 5.35Cr 5.43Cr 38Cr 15Cr 184.17Cr 14Cr 14Cr 591.54Cr
Net income 17Cr 17.34L 15.4L 14.4L 13.13L 24.71L 25.05L 1.74Cr 67.46L 8.5Cr 65.11L 63.7L 27Cr 12Cr 12.88L 11.44L 10.7L 10L 18.35L 18.61L 1.29Cr 50.1L 6.32Cr 48.36L 47.31L 20Cr
Net Debt 77Cr 79.72L 70.81L 66.22L 60.34L 1.14Cr 1.15Cr 8.01Cr 3.1Cr 39Cr 2.99Cr 2.93Cr 125.56Cr 88Cr 91.84L 81.57L 76.28L 69.52L 1.31Cr 1.33Cr 9.23Cr 3.57Cr 45Cr 3.45Cr 3.37Cr 144.64Cr
Logo Shivalik Rasayan Limited
Shivalik Rasayan Limited is an India-based company. The Company’s segments are engaged in agrochemicals, active pharma ingredients (API), and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Company’s oncology products include Azacitidine, Busulfan, Bortezomib, and various others.
Employees
342
Date Price Change Volume
01/26/01 ₹392.55 -2.24% 9,351
30/26/30 ₹401.55 -1.93% 1,442
29/26/29 ₹409.45 -0.09% 6,894
28/26/28 ₹409.80 +0.44% 3,623
25/26/25 ₹408.00 -0.32% 3,939
  1. Stock Market
  2. Stocks
  3. SHIVALIK Stock